These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 2108953

  • 21. Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2.
    Fung-Tomc JC, Gradelski E, Kolek B, Minassian B, Pucci M, Kessler RE, Bonner DP.
    Antimicrob Agents Chemother; 1995 Feb; 39(2):386-93. PubMed ID: 7726503
    [Abstract] [Full Text] [Related]

  • 22. Affinity of cefonicid, a long-acting cephalosporin, for the penicillin-binding proteins of Escherichia coli K-12.
    Rake JB, Newman DJ, Actor P.
    J Antibiot (Tokyo); 1984 May; 37(5):572-6. PubMed ID: 6376452
    [Abstract] [Full Text] [Related]

  • 23. Target affinities of faropenem to and its impact on the morphology of gram-positive and gram-negative bacteria.
    Dalhoff A, Nasu T, Okamoto K.
    Chemotherapy; 2003 Jul; 49(4):172-83. PubMed ID: 12886052
    [Abstract] [Full Text] [Related]

  • 24. Structure-activity relationships of carbapenems that determine their dependence on porin protein D2 for activity against Pseudomonas aeruginosa.
    Fung-Tomc JC, Huczko E, Banville J, Ménard M, Kolek B, Gradelski E, Kessler RE, Bonner DP.
    Antimicrob Agents Chemother; 1995 Feb; 39(2):394-9. PubMed ID: 7726504
    [Abstract] [Full Text] [Related]

  • 25. Antibacterial properties of SCE-2787, a new cephem antibiotic.
    Nakao M, Noji Y, Iwahi T, Yamazaki T.
    J Antimicrob Chemother; 1992 May; 29(5):509-18. PubMed ID: 1624391
    [Abstract] [Full Text] [Related]

  • 26. Imipenem resistance in Acinetobacter baumanii is due to altered penicillin-binding proteins.
    Gehrlein M, Leying H, Cullmann W, Wendt S, Opferkuch W.
    Chemotherapy; 1991 May; 37(6):405-12. PubMed ID: 1760939
    [Abstract] [Full Text] [Related]

  • 27. [Affinity of penicillin-binding proteins of Escherichia coli K-12 for furbenicillin and other beta-lactam antibiotics].
    Lei Y, Li JT.
    Zhongguo Yao Li Xue Bao; 1989 Mar; 10(2):177-80. PubMed ID: 2683579
    [Abstract] [Full Text] [Related]

  • 28. Binding of latamoxef (moxalactam) and its decarboxylated derivative to Escherichia coli and Pseudomonas aeruginosa penicillin-binding proteins.
    Labia R, Baron P, Masson JM.
    J Antimicrob Chemother; 1985 Jan; 15(1):9-15. PubMed ID: 3918982
    [Abstract] [Full Text] [Related]

  • 29. The affinity of imipenem (N-formimidoylthienamycin) for the penicillin-binding proteins of Staphylococcus aureus--binding and release.
    Hashizume T, Park W, Matsuhashi M.
    J Antibiot (Tokyo); 1984 Sep; 37(9):1049-53. PubMed ID: 6334067
    [Abstract] [Full Text] [Related]

  • 30. Antibacterial activity and penicillin-binding protein affinity of new cephalosporin derivatives in Staphylococcus aureus and Escherichia coli.
    Singh MP, Lee YI, Singh R, Micetich RG, Wilkinson BJ.
    J Antimicrob Chemother; 1991 Apr; 27(4):459-68. PubMed ID: 1856125
    [Abstract] [Full Text] [Related]

  • 31. Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: delay between killing by ceftazidime and imipenem and release of LPS.
    van Langevelde P, Kwappenberg KM, Groeneveld PH, Mattie H, van Dissel JT.
    Antimicrob Agents Chemother; 1998 Apr; 42(4):739-43. PubMed ID: 9559775
    [Abstract] [Full Text] [Related]

  • 32. Radiolabelling of penicillin-binding proteins (PBPs) in intact Pseudomonas aeruginosa cells: consequences of beta-lactamase activity by PBP-5.
    Livermore DM.
    J Antimicrob Chemother; 1987 Jun; 19(6):733-42. PubMed ID: 3112099
    [Abstract] [Full Text] [Related]

  • 33. Penicillin-binding proteins and induction of AmpC beta-lactamase.
    Sanders CC, Bradford PA, Ehrhardt AF, Bush K, Young KD, Henderson TA, Sanders WE.
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2013-5. PubMed ID: 9303404
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Penicillin-binding protein 5 as an inhibitory target of cefozopran in Enterococcus faecalis.
    Tsuchimori N, Okonogi K.
    J Antimicrob Chemother; 1996 Mar; 37(3):605-9. PubMed ID: 9182117
    [Abstract] [Full Text] [Related]

  • 36. Effect on growth curves and killing curves of brief exposure of Escherichia coli to imipenem and piperacillin.
    Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():61-5. PubMed ID: 3546248
    [Abstract] [Full Text] [Related]

  • 37. Clinical perspectives on imipenem.
    Neu HC.
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():149-53. PubMed ID: 6583196
    [No Abstract] [Full Text] [Related]

  • 38. Activity of FCE 22101 against methicillin-resistant Staphylococcus aureus and affinity for penicillin binding proteins.
    Piddock LJ, Traynor EA, Wise R.
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():59-64. PubMed ID: 2732144
    [Abstract] [Full Text] [Related]

  • 39. PBP binding and periplasmic concentration as determinants of the antibacterial activities of three new oral cephalosporins in Escherichia coli.
    Cornaglia G, Ligozzi M, Bauernfeind A, Satta G, Fontana R.
    New Microbiol; 1994 Jul; 17(3):203-10. PubMed ID: 7968655
    [Abstract] [Full Text] [Related]

  • 40. Contributions of PBP 5 and DD-carboxypeptidase penicillin binding proteins to maintenance of cell shape in Escherichia coli.
    Nelson DE, Young KD.
    J Bacteriol; 2001 May; 183(10):3055-64. PubMed ID: 11325933
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.